The classification, functions and clinical use of different isoforms of HCG.
HCG is composed of two subunits, HCGalpha and HCGbeta. During early pregnancy, HCG stimulates progesterone production in the corpus luteum, and injection of HCG is widely used to induce ovulation in assisted reproduction treatment (ART). Under experimental conditions, the free subunits have been shown to exert functions other than those of HCG, but the relevance of these remains to be determined. Intact HCG, free subunits and degraded forms of these occur in biological fluids, and determinations of these are important for diagnosis and monitoring of pregnancy, pregnancy-related disorders and several types of cancer. Development of optimal methods for the various forms has been hampered by lack of appropriate standards and expression of the concentrations of the various forms in units that are not comparable. Furthermore, the nomenclature for HCG assays is confusing and in some cases misleading. These problems can now be solved; a uniform nomenclature has been established, and new standards are available for HCG, its subunits HCGalpha and HCGbeta, the partially degraded or nicked forms of HCG and HCGbeta, and the beta-core fragment. This review describes the biochemical and biological background for the clinical use of determinations of various forms of HCG. The clinical use of HCG and studies on HCG vaccines are briefly reviewed.
Stenman
Ulf-Håkan
UH
Department of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland. ulf-hakan.stenman@hus.fi
Tiitinen
Aila
A
Alfthan
Henrik
H
Valmu
Leena
L
D006063:Chorionic Gonadotropin / Q000032:analysis / Q000145:classification / Q000502:physiology* / Q000627:therapeutic use*; D000939:Epitopes; D005260:Female; D031901:Gestational Trophoblastic Disease / Q000175:diagnosis; D006801:Humans; D005810:Multigene Family; D010062:Ovulation Induction / Q000379:methods; D011247:Pregnancy; D011258:Pregnancy Tests; D020033:Protein Isoforms; D011863:Radioimmunoassay; D011994:Recombinant Proteins / Q000627:therapeutic use; D012015:Reference Standards; D012016:Reference Values; D012680:Sensitivity and Specificity; D014594:Uterine Neoplasms / Q000175:diagnosis
D006063:Chorionic Gonadotropin; D000939:Epitopes; D020033:Protein Isoforms; D011994:Recombinant Proteins